BioMarin Pharmaceutical Says Co Will Be Entitled To Draw Funds At Its Discretion Until Revolving Credit Facility Matures On Aug 28, 2029
Portfolio Pulse from Benzinga Newsdesk
BioMarin Pharmaceutical has announced that it will have the ability to draw funds at its discretion from a revolving credit facility until its maturity on August 28, 2029, as per an SEC filing.
September 04, 2024 | 4:58 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BioMarin Pharmaceutical has secured a revolving credit facility allowing it to draw funds at its discretion until August 28, 2029. This provides the company with financial flexibility and liquidity.
The ability to draw funds at discretion from a revolving credit facility provides BioMarin with increased financial flexibility and liquidity. This is a positive development as it ensures the company can manage its cash flow needs effectively until 2029.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100